SON logo

Sonoco Products (SON) News & Sentiment

Sonoco Implementing Price Increases for Uncoated Recycled Paperboard, Converted Paperboard Products
Sonoco Implementing Price Increases for Uncoated Recycled Paperboard, Converted Paperboard Products
Sonoco Implementing Price Increases for Uncoated Recycled Paperboard, Converted Paperboard Products
SON
globenewswire.comMarch 10, 2025

HARTSVILLE, S.C., March 10, 2025 (GLOBE NEWSWIRE) -- Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), a global leader in high-value sustainable paper and metal packaging, today announced it is implementing a $70 per ton price increase for all grades of uncoated recycled paperboard (URB) in the United States and Canada, effective with shipments beginning April 10, 2025.

Sonoco Products: Pessimism Appears Overdone
Sonoco Products: Pessimism Appears Overdone
Sonoco Products: Pessimism Appears Overdone
SON
seekingalpha.comMarch 7, 2025

Sonoco Products' shares have underperformed, down 19% over the past year, and are currently near a 52-week low. Sonoco's Q4 results were impacted by the Eviosys acquisition, causing messy financials and increased debt, but future EPS contributions should build throughout 2025. Management turnover and asset sales add uncertainty, with cash flow guidance disappointing despite expected EPS growth.

Sonnet BioTherapeutics Presents Compilation of Data Highlighting the Potential of SON-1010 as a Monotherapy or a Combination Therapy to Improve the Treatment of Solid Tumors
Sonnet BioTherapeutics Presents Compilation of Data Highlighting the Potential of SON-1010 as a Monotherapy or a Combination Therapy to Improve the Treatment of Solid Tumors
Sonnet BioTherapeutics Presents Compilation of Data Highlighting the Potential of SON-1010 as a Monotherapy or a Combination Therapy to Improve the Treatment of Solid Tumors
SON
globenewswire.comFebruary 26, 2025

Poster presented at the 2025 AACR:IO Conference Company's novel platform that delivers either mono- or bifunctional immunomodulators linked to a Fully-Human, Albumin Binding scFv domain (F H AB ® )  provides enhanced targeting to the tumor microenvironment (TME) and prolonged retention in the tumor PRINCETON, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced the presentation of a compilation of data at the 2025 American Association for Cancer Research (AACR) IO Conference.

Why Sonoco (SON) is a Top Value Stock for the Long-Term
Why Sonoco (SON) is a Top Value Stock for the Long-Term
Why Sonoco (SON) is a Top Value Stock for the Long-Term
SON
zacks.comFebruary 21, 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Sonoco Earnings Miss Estimates in Q4, Sales Increase 2% Y/Y
Sonoco Earnings Miss Estimates in Q4, Sales Increase 2% Y/Y
Sonoco Earnings Miss Estimates in Q4, Sales Increase 2% Y/Y
SON
zacks.comFebruary 20, 2025

SON's Q4 top line reflects low single-digit volume gains and the contribution from Eviosys, offset by the impact of the divestiture of Protexic and lower selling prices.

Sonoco Products Company (SON) Q4 2024 Earnings Call Transcript
Sonoco Products Company (SON) Q4 2024 Earnings Call Transcript
Sonoco Products Company (SON) Q4 2024 Earnings Call Transcript
SON
seekingalpha.comFebruary 19, 2025

Sonoco Products Company (NYSE:SON ) Q4 2024 Earnings Conference Call February 19, 2024 8:30 AM ET Company Participants Roger Schrum - Interim Head, Investor Relations and Communications Howard Coker - President and CEO Jerry Cheatham - Interim CFO Rodger Fuller - COO Conference Call Participants George Staphos - Bank of America Bryan Burgmeier - Citi Matt Roberts - Raymond James Mark Weintraub - Seaport Research Partners Mike Roxland - Truist Securities Richard Carlson - Wells Fargo Operator Thank you for standing by, and welcome to the Sonoco Fourth Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise.

CORRECTION – Sonoco Reports Fourth Quarter and Full Year 2024 Results
CORRECTION – Sonoco Reports Fourth Quarter and Full Year 2024 Results
CORRECTION – Sonoco Reports Fourth Quarter and Full Year 2024 Results
SON
globenewswire.comFebruary 18, 2025

HARTSVILLE, S.C., Feb. 18, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Sonoco Products Company (NYSE: SON), please note that the cash flow from operating activities under Full-Year 2025 Guidance should be $800 million to $900 million, not $750 million to $850 million as previously stated.

Sonoco (SON) Lags Q4 Earnings and Revenue Estimates
Sonoco (SON) Lags Q4 Earnings and Revenue Estimates
Sonoco (SON) Lags Q4 Earnings and Revenue Estimates
SON
zacks.comFebruary 18, 2025

Sonoco (SON) came out with quarterly earnings of $1.17 per share, missing the Zacks Consensus Estimate of $1.18 per share. This compares to earnings of $1.02 per share a year ago.

Sonoco Reports Fourth Quarter and Full Year 2024 Results
Sonoco Reports Fourth Quarter and Full Year 2024 Results
Sonoco Reports Fourth Quarter and Full Year 2024 Results
SON
globenewswire.comFebruary 18, 2025

HARTSVILLE, S.C., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), a global leader in high-value sustainable packaging, today reported financial results for its fourth quarter and fiscal year ended December 31, 2024.

Zacks Industry Outlook Packaging Corporation of America,  Amcor, AptarGroup  and Sonoco Products
Zacks Industry Outlook Packaging Corporation of America,  Amcor, AptarGroup  and Sonoco Products
Zacks Industry Outlook Packaging Corporation of America, Amcor, AptarGroup and Sonoco Products
SON
ZacksFebruary 13, 2025

This Industry Outlook article features Packaging Corporation of America, Amcor, AptarGroup, and Sonoco Products.